Teva drops 8% on guidance, manufacturing problems
February 08, 2018 at 10:51 AM EST
A Food and Drug Administration warning letter received by one of Teva’s partners is expected to delay approval of as many as three new drugs.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.